Enzon Pharmaceuticals Down Almost 30% YTD

Enzon Pharmaceuticals Inc

is currently trading at $0.46 down 0.02 from the previous close of $0.48. The stock is trading at a P/C of 1.05, cheaper than peers. Profitability metrics are higher than industry averages, along with operating (68.9 percent) and profit (72.8 percent) margins higher than averages. Over the past year, shares are nearly flat but are down 30 percent year-to-date.